RxSight, Inc. (RXST)
6.375
-0.16
(-2.52%)
USD |
NASDAQ |
Sep 04, 16:00
6.30
-0.08
(-1.18%)
After-Hours: 20:00
RxSight Research and Development Expense (Quarterly) : 9.237M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.237M |
| March 31, 2026 | 9.472M |
| December 31, 2025 | 8.905M |
| September 30, 2025 | 9.06M |
| June 30, 2025 | 10.22M |
| March 31, 2025 | 10.37M |
| December 31, 2024 | 9.207M |
| September 30, 2024 | 8.838M |
| June 30, 2024 | 8.291M |
| March 31, 2024 | 8.031M |
| December 31, 2023 | 7.341M |
| September 30, 2023 | 7.101M |
| Date | Value |
|---|---|
| June 30, 2023 | 7.401M |
| March 31, 2023 | 7.208M |
| December 31, 2022 | 6.681M |
| September 30, 2022 | 6.388M |
| June 30, 2022 | 6.192M |
| March 31, 2022 | 6.719M |
| December 31, 2021 | 5.916M |
| September 30, 2021 | 5.377M |
| June 30, 2021 | 6.563M |
| March 31, 2021 | 6.643M |
| June 30, 2020 | 5.084M |
| March 31, 2020 | 5.777M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Precision Optics Corp., Inc. | 0.2673M |
| Alcon AG | 663.00M |
| UFP Technologies, Inc. | -- |
| TransMedics Group, Inc. | 31.63M |
| Hyperfine, Inc. | 3.865M |